← FDA DRUG APPROVALS

FDA ANDA · ANDA040862

PRIMIDONE

Sponsor: CHARTWELL RX

APPLICATION
ANDA040862
TYPE
ANDA
ORIGINAL APPROVAL
2008-10-03
LATEST ACTION
2011-11-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PRIMIDONEDiscontinued
PRIMIDONE 50MG · TABLET · ORAL
PRIMIDONEDiscontinued
PRIMIDONE 250MG · TABLET · ORAL

Approval history

2011-11-17REMS · Supplement 4AP
2011-09-20Labeling · Supplement 2AP
2010-11-30Labeling · Supplement 1AP
2008-10-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →